A novel promoter for the 11β-hydroxysteroid dehydrogenase type 1 gene is active in lung and is C/EBPα independent

Endocrinology

Volumn 147, Issue 6, 2006, Pages 2879-2885

  Bruley, Charlotte ^a   Lyons, Val ^a   Worsley, Alan G F ^a   Wilde, Margaret D ^b   Darlington, Gretchen D ^b   Morton, Nik M ^a   Seckl, Jonathan R ^a   Chapman, Karen E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; BINDING PROTEIN; ENHANCER BINDING PROTEIN ALPHA; LEPTIN; MESSENGER RNA; UNCLASSIFIED DRUG; CCAAT ENHANCER BINDING PROTEIN ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; EXON; GENE ACTIVATION; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TISSUE SPECIFICITY; ADIPOSE TISSUE; ANIMAL; ANTIBODY SPECIFICITY; C57BL MOUSE; ENZYMOLOGY; GENETIC TRANSCRIPTION; GENETICS; LUNG; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROMOTER REGION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOSE TISSUE; ANIMALS; BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; LUNG; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

EID: 33646874547     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-1621     Document Type: Article

References (53)

1. Seckl JR 2004 11β-Hydroxysteroid dehydrogenases: changing glucocorticoid action. Curr Opin Pharmacol 4:597-602
2. Draper N, Stewart PM 2005 11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. J Endocrinol 186:251-271
3. Atanasov AG, Nashev LG, Schweizer RA, Frick C, Odermatt A 2004 Hexose-6-phosphate dehydrogenase determines the reaction direction of 11β-hydroxysteroid dehydrogenase type 1 as an oxoreductase. FEBS Lett 571:129-133
4. Bujalska IJ, Draper N, Michailidou Z, Tomlinson JW, White PC, Chapman KE, Walker EA, Stewart PM 2005 Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11β-hydroxysteroid dehydrogenase type 1. J Mol Endocrinol 34:675-684
5. Rajan V, Chapman KE, Lyons V, Jamieson P, Mullins JJ, Edwards CRW, Seckl JR 1995 Cloning sequencing and tissue-distribution of mouse 11β- hydroxysteroid dehydrogenase-1 cDNA. J Steroid Biochem Mol Biol 52:141-147
6. Speirs HJ, Seckl JR, Brown RW 2004 Ontogeny of glucocorticoid receptor and 11β-hydroxysteroid dehydrogenase type-1 gene expression identifies potential critical periods of glucocorticoid susceptibility during development. J Endocrinol 181:105-116
7. Napolitano A, Voice MW, Edwards CRW, Seckl JR, Chapman KE 1998 11β-hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated. J Steroid Biochem Molec Biol 64:251-260
8. Livingstone DEW, Jones GC, Smith K, Jamieson PM, Andrew R, Kenyon CJ, Walker BR 2000 Understanding the role of glucocorticoids in obesity: tissuespecific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 141:560-563
9. Rask E, Olsson T, Söderberg S, Andrew R, Livingstone DE, Johnson O, Walker BR 2001 Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 86:1418-1421
10. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS 2001 A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166-2170
11. Bujalska IJ, Kumar S, Stewart PM 1997 Does central obesity reflect "Cushing's disease of the omentum"? Lancet 349:1210-1213
12. Seckl JR, Morton NM, Chapman KE, Walker BR 2004 Glucocorticoids and 11β-hydroxysteroid dehydrogenase in adipose tissue. Recent Prog Horm Res 59:359-393
13. Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ, Seckl JR, Flier JS 2003 Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 112:83-90
14. Morton NM, Holmes MC, Fievet C, Staels B, Mullins JJ, Seckl JR 2001 Improved lipid and lipoprotein profile, hepatic insulin sensitivity and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 276:41293-41300
15. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CRW, Seckl JR, Mullins JJ 1997 11β-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid inducible responses and resist hyperglycaemia on obesity or stress. Proc Natl Acad Sci USA 94:14924-14929
16. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, Walker BR, Flier JS, Mullins JJ, Seckl JR 2004 Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11β-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53:931-938
17. Alberts P, Engblom L, Edling N, Forsgren M, Klingstrom G, Larsson C, Ronquist-Nii Y, Ohman B, Abrahmsen L 2002 Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia 45:1528-1532
18. Alberts P, Nilsson C, Selen G, Engblom LO, Edling NH, Norling S, Klingstrom G, Larsson C, Forsgren M, Ashkzari M, Nilsson CE, Fiedler M, Bergqvist E, Ohman B, Bjorkstrand E, Abrahmsen LB 2003 Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 144:4755-4762
19. Walker BR, Connacher AA, Lindsay RM, Webb DJ, Edwards CRW 1995 Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J Clin Endocrinol Metab 80:3155-3159
20. Andrews RC, Rooyackers O, Walker BR 2003 Effects of the 11β-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab 88:285-291
21. Maser E, Oppermann UC 1997 Role of type-1 11β-hydroxysteroid dehydrogenase in detoxification processes. Eur J Biochem 249:365-369
22. Hundertmark S, Dill A, Ebert A, Zimmermann B, Kotelevtsev YV, Mullins JJ, Seckl JR 2002 Foetal lung maturation in 11β-hydroxysteroid dehydrogenase type 1 knockout mice. Horm Metab Res 34:545-549
23. Maser E, Richter E, Friebertshauser J 1996 The identification of 11β-hydroxysteroid dehydrogenase as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Eur J Biochem 238:484-489
24. Finckh C, Atalla A, Nagel G, Stinner B, Maser E 2001 Expression and NNK reducing activities of carbonyl reductase and 11β-hydroxysteroid dehydrogenase type 1 in human lung. Chem Biol Interact 130-132:761-773
25. Escher G, Galli I, Vishwanath BS, Frey BM, Frey FJ 1997 Tumor necrosis factor α and interleukin 1β enhance the cortisone/cortisol shuttle. J Exp Med 186:189-198
26. Tomlinson JW, Moore J, Cooper MS, Bujalska I, Shahmanesh M, Burt C, Strain A, Hewison M, Stewart PM 2001 Regulation of expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology 142:1982-1989
27. Cai T, Wong B, Mundt SS, Thieringer R, Wright SD, Hermanowski-Vosatka A 2001 Induction of 11β-hydroxysteroid dehydrogenase type 1 but not -2 in human aortic smooth muscle cells by inflammatory stimuli. J Steroid Biochem Mol Biol 77:117-122
28. Cooper MS, Bujalska I, Rabbitt E, Walker EA, Bland R, Sheppard MC, Hewison M, Stewart PM 2001 Modulation of 11β-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation. J Bone Miner Res 16:1037-1044
29. Tetsuka M, Haines LC, Milne M, Simpson GE, Hillier SG 1999 Regulation of 11β-hydroxysteroid dehydrogenase type 1 gene expression by LH and interleukin-1β in cultured rat granulosa cells. J Endocrinol 163:417-423
30. Yong PY, Harlow C, Thong KJ, Hillier SG 2002 Regulation of 11β-hydroxysteroid dehydrogenase type 1 gene expression in human ovarian surface epithelial cells by interleukin-1. Hum Reprod 17:2300-2306
31. Low SC, Chapman KE, Edwards CRW, Wells T, Robinson ICAF, Seckl JR 1994 Sexual dimorphism of hepatic 11β-hydroxysteroid dehydrogenase in the rat; the role of growth hormone patterns. J Endocrinol 143:541-548
32. Hermanowski-Vosatka A, Gerhold D, Mundt SS, Loving VA, Lu M, Chen Y, Elbrecht A, Wu M, Doebber T, Kelly L, Milot D, Guo Q, Wang PR, Ippolito M, Chao YS, Wright SD, Thieringer R 2000 PPARα agonists reduce 11β-hydroxysteroid dehydrogenase type 1 in the liver. Biochem Biophys Res Commun 279:330-336
33. Berger J, Tanen M, Elbrecht A, Hermanowski-Vosatka A, Moller DE, Wright SD, Thieringer R 2001 PPARγ ligands inhibit adipocyte 11β- hydroxysteroid dehydrogenase type 1 expression and activity. J Biol Chem 276:12629-12635
34. Stulnig TM, Oppermann U, Steffensen KR, Schuster GU, Gustafsson JA 2002 Liver X receptors downregulate 11β-hydroxysteroid dehydrogenase type 1 expression and activity. Diabetes 51:2426-2433
35. Jamieson PM, Chapman KE, Edwards CRW, Seckl JR 1995 11β- Hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology 136:4754-4761
36. Williams LJS, Lyons V, MacLeod I, Rajan V, Darlington GJ, Poli V, Seckl JR, Chapman KE 2000 C/EBP regulates hepatic transcription of 11β-hydroxysteroid dehydrogenase type 1; a novel mechanism for cross talk between the C/EBP and glucocorticoid signalling pathways. J Biol Chem 275:30232-30239
37. Wu Z, Rosen ED, Brun R, Hauser S, Adelmant G, Troy AE, McKeon C, Darlington GJ, Spiegelman BM 1999 Cross-regulation of C/EBPα and PPARγ controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell 3:151-158
38. Wang L, Shao J, Muhlenkamp P, Liu S, Klepcyk P, Ren J, Friedman JE 2000 Increased insulin receptor substrate-1 and enhanced skeletal muscle insulin sensitivity in mice lacking CCAAT/enhancer-binding protein-β. J Biol Chem 275:14173-14181
39. Moisan M-P, Edwards CRW, Seckl JR 1992 Differential promoter usage by the rat 11β-hydroxysteroid dehydrogenase gene. Mol Endocrinol 6:1082-1087
40. Mercer W, Obeyesekere V, Smith R, Krozowski Z 1993 Characterization of 11β-HSD1B gene expression and enzymatic activity. Mol Cell Endocrinol 92:247-251
41. Obeid J, Curnow KM, Aisenberg J, White PC 1993 Transcripts originating in intron-1 of the HSD11 (11β-hydroxysteroid dehydrogenase) gene encode a truncated polypeptide that is enzymatically inactive. Mol Endocrinol 7:154-160
42. Oppermann UCT, Netter KJ, Maser E 1995 Cloning and primary structure of murine β-hydroxysteroid dehydrogenase microsomal carbonyl reductase. Eur J Biochem 227:202-208
43. Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsayed SV, Wilde MD, Taylor LR, Wilson DR, Darlington GJ 1995 Impaired energy homeostasis in C/EBPα knockout mice. Science 269:1108-1112
44. Voice MW, Seckl JR, Edwards CRW, Chapman KE 1996 11β-Hydroxysteroid dehydrogenase type 1 expression in 2S-FAZA hepatoma cells is hormonally regulated; a model system for the study of hepatic glucocorticoid metabolism. Biochem J 317:621-625
45. Linhart HG, Ishimura-Oka K, DeMayo F, Kibe T, Repka D, Poindexter B, Bick RJ, Darlington GJ 2001 C/EBPα is required for differentiation of white, but not brown, adipose tissue. Proc Natl Acad Sci USA 98:12532-12537
46. Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G 1976 A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 17:62-70
47. Brereton PS, van Driel RR, Suhaimi F, Koyama K, Dilley R, Krozowski Z 2001 Light and electron microscopy localization of the 11β-hydroxysteroid dehydrogenase type I enzyme in the rat. Endocrinology 142:1644-1651
48. Li F, Rosenberg E, Smith CI, Notarfrancesco K, Reisher SR, Shuman H, Feinstein SI 1995 Correlation of expression of transcription factor C/EBPα and surfactant protein genes in lung cells. Am J Physiol 269:L241-247
49. Flodby P, Barlow C, Kylefjord H, Ahrlund-Richter L, Xanthopoulos KG 1996 Increased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein-α. J Biol Chem 271:24753-24760
50. Rolland V, Leliepvre X, Houbiguian ML, Lavau M, Dugail I 1995 C/EBPα expression in adipose tissue of genetically obese Zucker rats. Biochem Biophys Res Commun 207:761-767
51. Krempler F, Breban D, Oberkofler H, Esterbauer H, Hell E, Paulweber B, Patsch W 2000 Leptin, peroxisome proliferator-activated receptor-β, and CCAAT/enhancer binding protein-α mRNA expression in adipose tissue of humans and their relation to cardiovascular risk factors. Arterioscler Thromb Vasc Biol 20:443-449
52. Russell L, Forsdyke DR 1991 A human putative lymphocyte G0/G1 switch gene containing a CpG-rich island encodes a small basic protein with the potential to be phosphorylated. DNA Cell Biol 10:581-591
53. Zandbergen F, Mandard S, Escher P, Tan NS, Patsouris D, Jatkoe T, Rojas-Caro S, Madore S, Wahli W, Tafuri S, Muller M, Kersten S 2005 The G0/G1 switch gene 2 is a novel PPAR target gene. Biochem J 392:313-324